LUMITO Share Price Performance
SEK 0.48
-0.46 (-48.83%)
Price SEK 0.48
Share PriceSEK 0.48
LUMITO Community Narratives
There are no narratives available yet.
Recent LUMITO News & Updates
No updates
Lumito AB (publ) Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.17
- Gross Margin
- 3,028.48%
- Net Profit Margin
- -56,749.18%
- Debt/Equity Ratio
- 0%
Lumito AB (publ) Competitors
About LUMITO
- Founded
- 2010
- Employees
- 10
- CEO
- WebsiteView website
Lumito AB (publ) engages in the medical research and development of imaging technology in Sweden. It offers tissue analysis system based on upconverting nanoparticles, including SCIZYS system combining labeling and imaging technologies to locate and measure biomarkers in tissue samples. The company’s technology addresses challenges in various application areas, such as drug development, academic research, and clinical diagnostics. Lumito AB (publ) was incorporated in 2010 and is headquartered in Lund, Sweden.
Swedish Market Performance
- 7 Days: -2.2%
- 3 Months: 3.1%
- 1 Year: 3.0%
- Year to Date: -0.9%
Over the last 7 days, the market has dropped 2.2%, driven by a loss of 2.5% in the Industrials sector. In the last 12 months the market has been flat overall. Looking forward, earnings are forecast to grow by 17% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading